Maxis Clinical Newsletter
Our newsletter covers services, the latest updates, thought leadership and our commitment to excellence. Lets Be Allies!
Newsletter Published monthly
Created by
Maxis Clinical Sciences
Editions
Diversity Action Plans Now Required by FDA for Sponsors of Certain Clinical…
Maxis Clinical Sciences on LinkedIn
Bringing New Treatments to Patients Faster with Regulatory-Grade Synthetic…
Maxis Clinical Sciences on LinkedIn
Payer Difficulties in Assessing New Therapies
Maxis Clinical Sciences on LinkedIn
Strategic Role of FSP in Drug Development
Maxis Clinical Sciences on LinkedIn
More from this author
ICH E6(R3) Guideline Developments
7mo
FDA’s Updated Approach to Clinical Trial Monitoring: A 2023 Overview
8mo
Non-Interventional Studies: Putting Real-World Data to Work
10mo